These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
231 related items for PubMed ID: 8651293
1. Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Berman DB, Wagner-Costalas J, Schultz DC, Lynch HT, Daly M, Godwin AK. Am J Hum Genet; 1996 Jun; 58(6):1166-76. PubMed ID: 8651293 [Abstract] [Full Text] [Related]
2. The founder mutations 185delAG and 5382insC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early-onset breast cancer patients among Ashkenazi women. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T. Am J Hum Genet; 1997 Mar; 60(3):505-14. PubMed ID: 9042909 [Abstract] [Full Text] [Related]
3. Founder BRCA1 and BRCA2 mutations in Ashkenazi Jews in Israel: frequency and differential penetrance in ovarian cancer and in breast-ovarian cancer families. Levy-Lahad E, Catane R, Eisenberg S, Kaufman B, Hornreich G, Lishinsky E, Shohat M, Weber BL, Beller U, Lahad A, Halle D. Am J Hum Genet; 1997 May; 60(5):1059-67. PubMed ID: 9150153 [Abstract] [Full Text] [Related]
4. Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer. Neuhausen S, Gilewski T, Norton L, Tran T, McGuire P, Swensen J, Hampel H, Borgen P, Brown K, Skolnick M, Shattuck-Eidens D, Jhanwar S, Goldgar D, Offit K. Nat Genet; 1996 May; 13(1):126-8. PubMed ID: 8673092 [Abstract] [Full Text] [Related]
5. A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Berman DB, Costalas J, Schultz DC, Grana G, Daly M, Godwin AK. Cancer Res; 1996 Aug 01; 56(15):3409-14. PubMed ID: 8758903 [Abstract] [Full Text] [Related]
6. BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer. Moslehi R, Chu W, Karlan B, Fishman D, Risch H, Fields A, Smotkin D, Ben-David Y, Rosenblatt J, Russo D, Schwartz P, Tung N, Warner E, Rosen B, Friedman J, Brunet JS, Narod SA. Am J Hum Genet; 2000 Apr 01; 66(4):1259-72. PubMed ID: 10739756 [Abstract] [Full Text] [Related]
7. Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Friedman LS, Szabo CI, Ostermeyer EA, Dowd P, Butler L, Park T, Lee MK, Goode EL, Rowell SE, King MC. Am J Hum Genet; 1995 Dec 01; 57(6):1284-97. PubMed ID: 8533757 [Abstract] [Full Text] [Related]
8. Frequency of the BRCA1 185delAG mutation among Jewish women with ovarian cancer and matched population controls. Muto MG, Cramer DW, Tangir J, Berkowitz R, Mok S. Cancer Res; 1996 Mar 15; 56(6):1250-2. PubMed ID: 8640808 [Abstract] [Full Text] [Related]
9. Mutational analyses of BRCA1 and BRCA2 in Ashkenazi and non-Ashkenazi Jewish women with familial breast and ovarian cancer. Shiri-Sverdlov R, Oefner P, Green L, Baruch RG, Wagner T, Kruglikova A, Haitchick S, Hofstra RM, Papa MZ, Mulder I, Rizel S, Bar Sade RB, Dagan E, Abdeen Z, Goldman B, Friedman E. Hum Mutat; 2000 Dec 15; 16(6):491-501. PubMed ID: 11102978 [Abstract] [Full Text] [Related]
10. BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Schubert EL, Lee MK, Mefford HC, Argonza RH, Morrow JE, Hull J, Dann JL, King MC. Am J Hum Genet; 1997 May 15; 60(5):1031-40. PubMed ID: 9150150 [Abstract] [Full Text] [Related]
11. A family with three germline mutations in BRCA1 and BRCA2. Liede A, Metcalfe K, Offit K, Brown K, Miller S, Narod SA, Moslehi R. Clin Genet; 1998 Sep 15; 54(3):215-8. PubMed ID: 9788724 [Abstract] [Full Text] [Related]
12. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Roa BB, Boyd AA, Volcik K, Richards CS. Nat Genet; 1996 Oct 15; 14(2):185-7. PubMed ID: 8841191 [Abstract] [Full Text] [Related]
13. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Oddoux C, Struewing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K. Nat Genet; 1996 Oct 15; 14(2):188-90. PubMed ID: 8841192 [Abstract] [Full Text] [Related]
14. A low frequency of non-founder BRCA1 mutations in Ashkenazi Jewish breast-ovarian cancer families. Phelan CM, Kwan E, Jack E, Li S, Morgan C, Aubé J, Hanna D, Narod SA. Hum Mutat; 2002 Nov 15; 20(5):352-7. PubMed ID: 12402332 [Abstract] [Full Text] [Related]
15. The 185delAG BRCA1 mutation originated before the dispersion of Jews in the diaspora and is not limited to Ashkenazim. Bar-Sade RB, Kruglikova A, Modan B, Gak E, Hirsh-Yechezkel G, Theodor L, Novikov I, Gershoni-Baruch R, Risel S, Papa MZ, Ben-Baruch G, Friedman E. Hum Mol Genet; 1998 May 15; 7(5):801-5. PubMed ID: 9536083 [Abstract] [Full Text] [Related]
18. Ashkenazi founder BRCA1/BRCA2 mutations in Slovak hereditary breast and/or ovarian cancer families. Cierniková S, Tomka M, Kovác M, Stevurková V, Zajac V. Neoplasma; 2006 May 15; 53(2):97-102. PubMed ID: 16575464 [Abstract] [Full Text] [Related]